Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

51.62 -0.91 (-1.73%)
Streaming Delayed Price Updated: 9:47 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
34 35 Next >
News headline image
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025 ↗
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025 
Via InvestorPlace
News headline image
Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday ↗
 
Via Benzinga
News headline image
Vertex Pharmaceuticals Stock: Bear vs. Bull ↗
Vertex has reached a key moment in its story. 
Via The Motley Fool
News headline image
3 Stocks That Every 20-Year-Old Should Buy Today ↗
When you’re just starting out in adult life, you have time on your side. Use it to your advantage with these stocks for young investors. 
Via InvestorPlace
News headline image
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023 ↗
If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead. 
Via InvestorPlace
News headline image
2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗
These companies are coming into their own. 
Via The Motley Fool
News headline image
Is CRISPR Therapeutics Stock a Buy Now? ↗
CRISPR stock has climbed more than 40% so far this year. 
Via The Motley Fool
News headline image
Where Will CRISPR Therapeutics Be in 10 Years? ↗
The biotech is part of a revolution in gene-editing therapies. 
Via The Motley Fool
News headline image
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks ↗
Reaching profitability could be harder than investors expect. 
Via The Motley Fool
News headline image
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond ↗
Both companies have therapies that should help grow revenue and earnings for years. 
Via The Motley Fool
News headline image
The Best Stocks to Invest $20,000 in Right Now ↗
You can invest in these companies with $20,000 -- or even a lot less. 
Via The Motley Fool
News headline image
Why Shares of Nkarta Are Slumping Tuesday ↗
The pharmaceutical stock dropped after announcing so-so clinical trial results. 
Via The Motley Fool
News headline image
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right. ↗
With two huge catalysts drawing near, its stock could go even higher. 
Via The Motley Fool
News headline image
What Is CRISPR And Why Should Your Portfolio Care? ↗
CRISPR Therapeutics continues to be at the forefront of CRISPR-based therapeutics development. It's the first, and largest, but not the only player. 
Via Talk Markets
News headline image
3 Monster Stocks in the Making to Buy Right Now ↗
They're not monsters now -- but just give them some time. 
Via The Motley Fool
News headline image
Alleged Industrial Espionage Makes an Interesting Story ↗
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment. 
Via The Motley Fool
News headline image
Cathie Wood Is Buying This Growth Stock and Selling Its Competitor. Should You Follow Suit? ↗
There's more than one reason to sell a stock while buying another. 
Via The Motley Fool
News headline image
Buying This Growth Stock Hand-Over-Fist Right Now Could Make You a Lot Wealthier by 2030 ↗
This company has several catalysts for growth coming up, with more on the way. 
Via The Motley Fool
News headline image
3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever ↗
Here are three long-term biotech stock investments that have the opportunity to turn risk -tolerant investors into millionaires. 
Via InvestorPlace
News headline image
Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy ↗
Success could be in the DNA of the Ark Invest founder. 
Via The Motley Fool
News headline image
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities ↗
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators... 
Via Talk Markets
News headline image
3 Cathie Wood Investments That Could Deliver Superior Returns ↗
These three stocks fit Wood's profile for big-time growth. 
Via The Motley Fool
News headline image
2 Short-Squeeze Candidates That Could Go Parabolic ↗
Editas Medicine and Bluebird Bio have been favorite targets for short-sellers lately. 
Via The Motley Fool
News headline image
This Move Is a First for the FDA. Could It Signal a Big Turning Point for CRISPR Therapeutics? ↗
All eyes are on CRISPR Therapeutics' gene editing technology. 
Via The Motley Fool
News headline image
5 Stocks to Buy With Explosive 500% Potential ↗
Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential. 
Via InvestorPlace
News headline image
2 Biotech Stocks That Could Help Make You a Fortune ↗
Biotech stocks with cutting-edge therapies have the potential to generate substantial returns over time. 
Via The Motley Fool
News headline image
3 No-Brainer Stocks to Buy in June ↗
These biopharma stocks could be big winners. 
Via The Motley Fool
News headline image
Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application ↗
The FDA has accepted the application for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG (NASDAQ: CRSP) exa-cel for sickle cell disease and transfusion-dependent  
Via Benzinga
News headline image
Vertex/CRISPR Partnered Cell Therapy Shows Encouraging In Sickle Cell Disease, Thalassemia Patients ↗
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP) announced that pivotal trials for exagamglogene autotemcel (exa-cel) for transfusion-dependent... 
Via Benzinga
News headline image
Carvana (CVNA) Stock Continues to Move on Improved Outlook ↗
Carvana (CVNA) stock is still a hot topic among traders on Friday after the used-car retailer updated its outlook yesterday. 
Via InvestorPlace
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.